Hematology IM Board Review
Approach to Anemia
-
Step 1: Kinetic view
-
Low retic â â production (iron, B12/folate lack, marrow failure)
-
High retic â â destruction/loss (hemolysis, blood loss, splenic sequestration)
-
-
Step 2: Morphologic view (MCV)
-
Microcytic (< 80) â iron deficiency vs thalassemia
-
Normocytic (80-100) â early iron-def, anemia of inflammation, CKD, hemolysis
-
Macrocytic (> 100) â B12/folate lack, MDS, liver, alcohol, drugs
-
Â
Microcytic Anemia Essentials
-
Iron deficiency
-
Buzz: pica, restless legs, low ferritin (< 40); reactive thrombocytosis common
-
Must do: search for occult blood â EGD/colonoscopy
-
-
Anemia of inflammation (chronic disease)
-
High ferritin, low TIBC, low/normal iron sat; treat underlying cause ± EPO
-
-
Thalassemia traits
-
Disproportionately low MCV (eg 55) with mild anemia
-
ÎČ-trait: â HbAâ on electrophoresis. α-trait: normal electrophoresis
-
Never give iron unless deficient
-
Â
Macrocytic Anemia Essentials
-
B12 deficiency
-
Clues: neuropathy, other autoimmune disease, pernicious anemia (IF Ab)
-
Borderline B12? Check MMA + homocysteine (both â)
-
-
Folate deficiency
-
Clues: alcoholism, pregnancy, rapid cell turnover, MTX
-
Only homocysteine â (MMA normal). No neurologic signs
-
-
Smear hallmark: macro-ovalocytes + hypersegmented neutrophils
Â
Hemolytic Anemias
Bucket | Examples | Key lab / smear | Special pearls |
---|---|---|---|
Intrinsic (hereditary) | Sickle cell, thalassemia major, G6PD, hereditary spherocytosis, PNH | â LDH, â indirect bili, â haptoglobin, â retic | G6PD assay after 2â3 mo; PNH â hemoglobinuria + thrombosis |
Extrinsic (acquired) | Autoimmune hemolysis (warm IgG, cold IgM), MAHA (TTP, HUS, DIC), mechanical | Direct Coombs + in autoimmune only | Warm â steroids; Cold â keep warm / treat cause |
Rapid identifiers
-
Hourglass spherocytes + â MCHC â hereditary spherocytosis
-
Bite cells + Heinz bodies â G6PD
-
Schistocytes + normal PT/PTT â TTP/HUS
-
Schistocytes + prolonged PT/PTT â DIC
-
Clot + heparin exposure â HIT (stop heparin, start argatroban)
Â
Bleeding & Clotting Framework
-
Primary hemostasis (platelets)
-
Superficial mucocutaneous bleeding
-
Low number: ITP (isolated), TTP/HUS/DIC/HIT (plus hemolysis)
-
Poor function: von Willebrand disease â prolonged bleeding time ± PTT; treat with DDAVP
-
-
Secondary hemostasis (coag factors)
-
Deep soft-tissue / hemarthrosis
-
Interpret PT/PTT + mixing study
-
PT only â â factor VII/VK/Liver/Warfarin
-
PTT only â â factors VIII, IX, XI, XII or inhibitor
-
Mix corrects â deficiency (eg hemophilia A)
-
Mix fails â inhibitor (APLS if clot; acquired VIII inhibitor if bleed)
-
-
Oddballs
-
Normal labs yet bleed â factor XIII defect
-
High PTT, no bleed â factor XII defect
-
-
Â
Transfusion Reactions (know the calls)
Time | Presentation | Diagnosis / Key test | Action |
---|---|---|---|
Minutes | Fever, flank pain | Acute hemolytic (ABO) w/ + direct Coombs | Stop transfusion, vigorous support |
Minutes | Fever only | Febrile non-hemolytic | Stop, then acetaminophen ± restart |
Hours | Dyspnea | TRALI (non-cardiogenic) vs TACO (volume) - BNP/JVD help differentiate | TRALI: stop + oxygen; TACO: diurese |
Days | Jaundice, â Hgb | Delayed hemolytic (Rh) | Supportive |
Â
Bone Marrow & Hematologic Malignancies
-
Aplastic anemia â  young, pancytopenia, hypocellular marrow; treat with transplant or ATG/cyclosporine
-
Myelodysplastic syndrome (MDS) â older, pancytopenia, hypercellular dysplastic marrow; risk AML; 5q- deletion responds to lenalidomide
-
Acute leukemias
-
AML: blasts > 20 %, ± auer rods (M3/APL t(15;17)â treat with ATRA; watch DIC)
-
ALL: blasts + CNS, nodes, hepatosplenomegaly; common in children
-
Hyperleukocytosis â leukostasis â emergent leukapheresis
-
-
Myeloproliferative neoplasms
-
CML: very high WBC with all myeloid stages; t(9;22) (BCR-ABL); treat with TKIs (imatinib etc)
-
Polycythemia vera & Essential thrombocythemia: JAK2+ (â100 % PV, 50 % ET); treat phlebotomy or hydroxyurea
-
-
Chronic lymphocytic leukemia (CLL)
-
Elderly, asymptomatic lymphocytosis + smudge cells; observe unless symptomatic; Richter transformation risk
-
-
Lymphomas
-
Aggressive (DLBCL, Burkitt) â symptomatic; curable with chemo (R-CHOP, high-grade regimens)
-
Indolent (follicular, marginal zone)â often watch-and-wait
-
Hodgkin: Reed-Sternberg âowl-eyeâ cells; ABVD; late toxicities (CAD, hypothyroid)
-
-
Plasma-cell disorders
-
Multiple myeloma: CRAB signs, M-spike on SPEP/UPEP, rouleaux; treat with chemo ± ASCT, bisphosphonates
-
MGUS (< 3 g/dL, < 10 % plasma cells, no CRAB)â yearly follow-up
-
Waldenström (IgM spike) â hyperviscosity; consider plasmapheresis
-
Â
High-Yield One-Liners
-
Iron-deficiency with platelets > 450 k  â reactive thrombocytosis, not leukemia
-
Sickle cell crisis + low retic â aplastic crisis (parvovirus B19)
-
Splenic sequestration crisis occurs in SC disease, not SS
-
Platelets < 30 k + bleeding â treat ITP (steroids IVIg); donât transfuse unless life-threatening bleed
-
Never give platelets in TTP or HIT
-
Pregnant DVT â treat with low-molecular-weight heparin
-
Back pain, anemia, creatinine rise, total protein â â order SPEP + UPEP for myeloma work-up